GlassScriptPhysician profile
Neena Grewal
NPI 1366410938
$8,153.61
in general payments reported to CMS, 2019-2025
26 companies · $568 in 2025
The $568 reported for 2025 was more than what 76% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,206 · 2020: $1,227 · 2021: $1,129 · 2022: $1,314 · 2023: $952 · 2024: $758 · 2025: $568.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,277.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,025.23 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Glaxosmithkline, LLC. | $977.82 | 2019-2023 | Arexvy, Trelegy Ellipta, Shingrix |
| Boston Scientific Corporation | $938.10 | 2019-2025 | Watchman Access System, Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $762.91 | 2019-2025 | Jardiance |
| Novo Nordisk INC | $526.67 | 2019-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $403.30 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Novartis Pharmaceuticals Corporation | $312.18 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $272.73 | 2019-2025 | Camzyos |
| Pfizer INC. | $257.60 | 2019-2024 | |
| Amarin Pharma, INC. | $255.48 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $211.33 | 2019-2022 | |
| Stryker Corporation | $136.53 | 2024 | Mako |
| Allergan, INC. | $135.18 | 2020 | |
| Nevro Corp. | $126.64 | 2023 | Senza |
| Seapearl East, INC | $126.27 | 2024 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $125.01 | 2022 | |
| Radius Health, INC. | $125.00 | 2019 | |
| Davol INC. | $119.86 | 2025 | Phasix Mesh |
| Kowa Pharmaceuticals America, INC. | $76.32 | 2020-2021 | |
| Genzyme Corporation | $67.09 | 2025 | |
| Janssen Pharmaceuticals, INC | $66.98 | 2019-2021 | |
| Sanofi Pasteur INC. | $37.49 | 2020-2021 | |
| Exact Sciences Corporation | $17.92 | 2023 | Cologuard Collection Kit |
| Ironwood Pharmaceuticals, INC | $17.76 | 2019 | |
| Avanir Pharmaceuticals, INC. | $16.21 | 2019 | |
| Seqirus USA INC | $16.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neena Grewal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.